Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Int J Cancer ; 151(7): 1120-1126, 2022 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-35567576

RESUMO

This longitudinal study aimed at evaluating the effectiveness, acceptability and safety of the thermal ablation procedure (TA) in the treatment of cervical neoplasia. Women referred to the Gynaecology ward for symptoms or for opportunistic screening were assessed by visual inspection with acetic acid (VIA) and colposcopy. Those with lesions eligible to ablation were counselled and treated by TA. They were inquired about the level of pain during the procedure, and their level of satisfaction. Patients were followed up at 6 weeks for any complication and reassessed by VIA and colposcopy at 12 months for any persistent or recurrent lesion and for any adverse event. A total of 86 women with a positive VIA test were included in the study. The mean age was 46 years (28-61 years). Most of the women did not complain about any adverse event during treatment; one-third presented mild pain or cramp. At the 6-week visit, watery discharge was the main adverse event reported. All women were highly satisfied with TA and most of them would recommend it. At the 12-month visit, 82 women were examined (95% follow-up rate), and the overall cure rate was 96% (low-grade lesions: 98%; high-grade lesions: 94%). Three women presented low- and high-grade lesions that were treated by TA. No major adverse event or hospitalisation after the treatment was reported. In conclusion, TA was an effective procedure with a high cure rate at the 1-year follow-up visit. It was acceptable and safe, with only minor short-term side-effects reported and with a high satisfaction rate among the patients.


Assuntos
Displasia do Colo do Útero , Neoplasias do Colo do Útero , Ácido Acético , Burundi , Colposcopia , Feminino , Humanos , Estudos Longitudinais , Pessoa de Meia-Idade , Dor , Gravidez , Neoplasias do Colo do Útero/diagnóstico , Displasia do Colo do Útero/diagnóstico
2.
Artigo em Inglês | MEDLINE | ID: mdl-38563768

RESUMO

OBJECTIVE: The objective of this study was to translate and validate the Revised Impact of Miscarriage Scale (RIMS) into Kirundi for use among women and men in Burundi. Additionally, the study aimed to compare the experience and personal meaning of miscarriage between women and men. METHODS: This is a cross-sectional multicentered study. The RIMS was translated into Kirundi. Cronbach coefficient alpha and its internal consistency were measured for both genders. An exploratory factor analysis (EFA) was used to determine the underlying factors and the shared variance. Both women and men completed the RIMS questionnaire, while women completed sociodemographic, reproductive and mental health questions. RESULTS: In all, 79 couples completed the RIMS. The original factor structure was retained after the EFA, with 68% of the shared variance explained in the three-factor solution with 16 questions. Isolation/guilt, Loss of baby, and Devastating event. The internal consistency for women and men combined was α = 0.928. Although women scored higher on the factors of Isolation/guilt and Loss of baby, there were no significant differences in the Devastating event factor between women and men. Couples scores were positively correlated. Women who had experienced a previous miscarriage were more significantly impacted by all three factors compared to women experiencing their first miscarriage. CONCLUSIONS: The Kirundi translation of the RIMS retained the original factor structure and demonstrated excellent internal consistency α = 0.928 in women and men combined. The RIMS could be a tool for caregivers to identify individuals who require additional support after a miscarriage.

3.
BMJ Open ; 14(5): e083546, 2024 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-38803254

RESUMO

OBJECTIVE: The Burundian emergency obstetric and neonatal care (EmONC) programme, which was initiated in 2017 and supported by a specific policy, does not appear to reverse maternal and newborn mortality trends. Our study examined the capacity challenges facing participating EmONC facilities and developed alternative investment proposals to improve their readiness paying particular attention to EmONC professionals, physical infrastructure, and capital equipment. DESIGN: Cross-sectional study. SETTING: Burundian EmONC facilities (n=112). PARTICIPANTS: We examined EmONC policy documents, consulted 12 maternal and newborn health experts and 23 stakeholders and policymakers, surveyed all EmONC facilities (n=112), and collected cost data from the Ministry of Health and local suppliers in Burundi. We developed three context-specific EmONC resource benchmark standards by facility type; the Burundian policy norms and the expert minimum and maximum suggested thresholds; and used these alternatives to estimate EmONC resource gaps. We forecasted three corresponding budget estimates needed to address prevailing deficits taking a government perspective for a 5-year EmONC investment strategy. Additionally, we explored relationships between EmONC professionals and selected measures of service delivery using bivariate analyses and graphically. RESULTS: The lowest EmONC resource benchmark revealed that 95% of basic EmONC and all comprehensive EmONC facilities lack corresponding sets of human resources and 90% of all facilities need additional physical infrastructure and capital equipment. Assessed against the highest benchmark which proposes the most progressive set of standards for the prevailing workloads, Burundi would require 162 more medical doctors, 1005 midwives and nurses, 132 delivery rooms, 191 delivery tables, 678 and 156 maternity and newborn care beds, and 395 incubators amounting to US$32.9 million additional budget for 5 years. CONCLUSION: We demonstrated that Burundian EmONC facilities face enormous capacity challenges equivalent to US$32.9 million funding gap for 5 years; averagely approximating to 5.96% total health budget increase annually.


Assuntos
Serviços de Saúde Materna , Humanos , Estudos Transversais , Recém-Nascido , Burundi , Feminino , Gravidez , Serviços de Saúde Materna/economia , Orçamentos , Serviços Médicos de Emergência/economia , Lactente , Mortalidade Materna/tendências , Mortalidade Infantil/tendências
4.
East Afr Health Res J ; 2(2): 128-134, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-34308183

RESUMO

BACKGROUND: The fertility rate in Burundi has remained consistently high since the 1980s, while the prevalence of contraceptive use in the country (22%) has been among the lowest in Africa. Reasons for low contraception uptake in Burundi have not been adequately clarified.This study aimed to identify factors associated with contraceptive use among pregnant women who had at least 3 healthy children and sought antenatal care services at an urban tertiary hospital in Burundi. METHODS: Data were collected from antenatal clients with 3 or more children at Kamenge University Hospital. Data analysis included univariate and multivariate methods as well as multiple logistic regression analysis using SPSS, version 16.0. RESULTS: We enrolled 255 women with a mean age of 32±4.5 years. The majority (n=232, 91.0%) of participants were urban residents with low incomes, and most (n=227, 89.0%) were educated to the primary school level or lower. The mean parity was 4.2±1.4, and most women had either 3 (n=120, 47.1%), 4 (n=66, 25.9%), or 5 (n=43, 16.9%) children; 26 (10%) participants had at least 6 children. Most (n=166, 65.1%) participants were part of couples who desired to have a final number of 4 to 6 children. About half (n=129, 50.6%) of the participants were able to name 1 or 2 benefits of contraception, and 105 (41.2%) participants mentioned 3 or 4 benefits of contraception. The most commonly reported benefit of contraceptive use was that it allows for improved maternal and child health. Low rates of contraceptive use were reported by participants with partners who worked as farmers, those citing fewer benefits of contraception, and those who relied on neighbours as their main source of information about contraception. CONCLUSION: Knowledge of the benefits of contraception was among the strongest determinants of contraceptive use in this population. Farmers and traders were less likely to use contraceptives than participants who were engaged in other types of work. Medical personnel were the most relied upon source of information about contraception, and the strongest predictor of contraceptive use was the personal opinion that contraception is acceptable.

5.
East Afr Health Res J ; 2(2): 112-117, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-34308181

RESUMO

BACKGROUND: Prevention of mother-to-child transmission (PMTCT) programmes aim to both eliminate vertical transmission of HIV and optimise the health and survival of infants born with HIV. Therefore, early infant diagnosis (EID) of HIV infection via DNA polymerase chain reaction (PCR) testing is a key component of PMTCT programming. We assessed the effectiveness of EID and PMTCT interventions at health-care facilities in Bujumbura, Burundi. METHODS: This was a prospective analytical study of infants born to HIV-positive mothers on antiretroviral therapy (ART), who were followed from December 2016 to March 2017 at 3 centres providing PMTCT services in Bujumbura. Babies enrolled in this study received once-daily nevirapine from birth through to 6 weeks of life, after which HIV DNA PCR testing was conducted. RESULTS: Of 122 HIV-exposed infants, 60 were boys and 62 were girls. The mother-to-child transmission rate at 6 weeks of life was 0.9%. Eighty-three (68%) of the women had commenced ART before pregnancy and 39 (32%) during pregnancy. The mean CD4 lymphocyte count was 653±308 cells/µl. Ninety-two (75.4%) of the pregnancies were planned, and 98 (80%) of the births were via spontaneous vaginal delivery. After birth, 111 (91.0%) infants were exclusively breastfed, and 11 (9.0%) infants received exclusive replacement feeding. CONCLUSION: There was a low rate of transmission of HIV from women taking ART to children who were given nevirapine for the first 6 weeks of life. Infants of HIV-positive women can live healthy lives free from HIV infection if their mothers participate in PMTCT programmes.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA